Navigation Links
ICON®microALB

ProductsICON®microALB
Company Beckman Coulter, Inc.
Item ICON®microALB
Features 
  • CLIA Waived
  • 18 mg/L sensitivity, 95% specificity
  • Albumin specific
  • Results in 3 minutes, readable up to 8 hours
  • Room temperature storage
  • Description ICON®microALB is a qualitative immunoassay for urinary albumin that allows for early detection of kidney disease. This albumin specific, CLIA Waived test has a sensitivity of 18 mg/L and specificity of 95%, and gives accurate results in only 3 minutes with stable viewing results up to 8 hours. Since early detection is one key to preventing kidney disease, the ICON®microALB allows the clinician to easily meet the National Kidney Foundation and American Diabetes Association guidelines for annual screening and has a unique design that allows for easy handling, superior readability and patient labeling right on the device. The ICON®microALB can be stored at room temperature and each dipstick is individually wrapped. Add this annual screening test to your Point-of-Care arsenal.
    Info Beckman Coulter, Inc.
    Customer Service: (800) 742-2345
    Web site: http://www.beckmancoulter.com

    Related medicine products :

    1. Donna® Saliva Ovulation Tester
    2. QED A350 Saliva Alcohol Test
    3. QED® A150 Saliva Alcohol Test
    4. Cortisol (Saliva)
    5. Cortisol, Saliva
    6. IgA, Saliva
    7. Immunoglobulin A, Saliva
    8. Alcoholic Giemsa Stain
    9. Ammonia/Alcohol Control
    10. Isopropyl Alcohol Liquid Pouch
    11. Acetone Alcohol Saturated Swabsticks
    ... QualiCode™ B. burgdorferi IgG/IgM Western Blot Kits ... detection of antibodies to Borrelia burgdorferi. Proteins ... disruption. Purified B. burgdorferi antigens are fractionated ... a polyacrylamide slab gel in the presence ...
    Surgitie&trade Single Use Ligating Loops with Delivery System...
    Surgitie&trade Single Use Ligating Loops with Delivery System...
    ENDO STITCH™ Single Use Loading Units....
    Medicine Products:
    (Date:7/20/2017)... (PRWEB) , ... July 20, 2017 , ... ... law firm headquartered in Houston, is pleased to announce their expansion to the ... affordable housing experience, directors Alysse Hollis and Ronald Bell, and of counsels, John ...
    (Date:7/20/2017)... ... ... Team Type 1 Foundation, a nonprofit organization pursuing a global mission of ... up with a Microsoft Corp. employee-led hackathon team for the 2017 Microsoft One Week ... Type 1’s mission overlaps seamlessly with Microsoft’s mission to empower every person and every ...
    (Date:7/20/2017)... ... July 20, 2017 , ... Girl Up Campaign Director, Melissa ... legislation in support of providing girls access to education in refugee settings. In May, ... “Protecting Girls’ Access to Education in Vulnerable Settings Act.” Yesterday, companion legislation was ...
    (Date:7/20/2017)... ... July 20, 2017 , ... TCGRx announced today ... existing adherence automation lines. The ATP® Mini and InspectRx® Mini are ... standard products, but at a size and price point that can help pharmacies ...
    (Date:7/20/2017)... ... July 20, 2017 , ... With ... 2014, top travel insurance solution company VisitorsCoverage Inc. has launched TMQuotes, a new ... international travel insurance products online, under their own brand. The online marketplace bridges ...
    Breaking Medicine News(10 mins):
    (Date:7/11/2017)... , July 11, 2017  Bayer has awarded grants ... countries as part of its prestigious Bayer Hemophilia Awards Program ... of Philadelphia and Uniformed Services University ... are among the winners. Grant recipients were announced last night ... Hemostasis (ISTH) 2017 Congress, Berlin, Germany . ...
    (Date:7/11/2017)... 2017  Sysmex America, Inc., a leading provider ... as well as middleware information systems technology, today ... quality assurance easier and more risk free than ... for the innovation that it delivers to the ... assurance processes to a new level with automated, ...
    (Date:7/11/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ORMP ... on the development of oral drug delivery systems, announced ... has agreed to schedule an End-of-Phase II meeting with ... its oral insulin capsule ORMD-0801 in the treatment of ... and secondary endpoints by indicating a statistically significant lowering ...
    Breaking Medicine Technology: